Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous vs Intravenous Vancomycin in Total Knee Arthroplasty
NCT05705843Phase 4Unknown
- Sponsor
- Houston Methodist Research Institute
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vancomycin in surgical site infection (SSI), sponsored by Houston Methodist Research Institute. Primary endpoints: Vancomycin Bone/Tissue Concentrations and Systemic Vancomycin Concentrations. Status: unknown.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05705843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705843.